Septerna (SEPN) Common Equity (2023 - 2026)
Septerna's quarterly Common Equity came in at $378.5 million in Q1 2026, up 194.55% year-on-year from $128.5 million in Q1 2025, and down 0.91% quarter-over-quarter from $381.9 million in Q4 2025.
Septerna has reported Common Equity for 4 years, with the latest figure at $378.5 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 194.55% year-over-year to $378.5 million; the trailing twelve-month figure through Mar 2026 stood at $378.5 million (up 194.55% YoY), and the FY2025 full-year result was $381.9 million, down 9.08% from the prior year.
- Common Equity for Q1 2026 stood at $378.5 million, down from $381.9 million in the prior quarter.
- The five-year high for Common Equity was $420.0 million in Q4 2024, with the low at -$400.3 million in Q1 2025.
- Average Common Equity over 4 years is $111.6 million, with a median of -$38.4 million recorded in 2023.
- Year-over-year, Common Equity surged 1194.61% in 2024 and slumped 671.31% in 2025.
- Tracing SEPN's Common Equity over 4 years: stood at -$38.4 million in 2023, then surged by 1194.61% to $420.0 million in 2024, then fell by 9.08% to $381.9 million in 2025, then decreased by 0.91% to $378.5 million in 2026.
- The last three Common Equity figures came in at $378.5 million (Q1 2026), $381.9 million (Q4 2025), and $388.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 378.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.46 Mn |
| Dec 31, 2025 | 381.93 Mn |
| Sep 30, 2025 | 388.73 Mn |
| Jun 30, 2025 | 377.56 Mn |
| Mar 31, 2025 | -400.27 Mn |
| Dec 31, 2024 | 420.05 Mn |
| Sep 30, 2024 | -87.41 Mn |
| Jun 30, 2024 | -67.76 Mn |
| Mar 31, 2024 | -51.89 Mn |
| Dec 31, 2023 | -38.37 Mn |
| Sep 30, 2023 | -73.85 Mn |